Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 06 Nov 2016
At a glance
- Drugs Cixutumumab (Primary) ; Temsirolimus (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 28 May 2015 Planned End Date changed from 1 Dec 2013 to 1 Jan 2016 as reported by ClinicalTrials.gov record.
- 01 Jul 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
- 14 Jan 2013 Planned end date changed from 1 Jan 2100 to 1 Dec 2013 as reported by ClinicalTrials.gov.